Posts by rw-admin
Saranas Announces First Commercial Case With Early Bird® Bleed Monitoring System in the U.S.
Saranas, Inc. announced completion of the first U.S. commercial case using the Early Bird® Bleed Monitoring System for real-time detection and monitoring of endovascular bleed complications. Dr. Robert Kipperman, co-director of the Structural Heart Disease Program at Morristown Medical Center, and Dr. Bledi Zaku, cardiothoracic surgeon, successfully used the Early Bird to monitor for bleed complications…
Read MoreEDAP to Introduce New Endo-UP Endourology Platform During the 2019 World Congress of Endourology
EDAP TMS SA, the global leader in therapeutic ultrasound, announced today the introduction of a new concept of Endourology Platform during the WCE congress, which is being held in Abu Dhabi, October 29 – November 2, 2019. Endo-UP® is a new conceptual product designed for the management of urinary stones. Responding to the rapidly evolving…
Read MoreIn2Bones Introduces CoLink Bone Graft Harvester And Tribio Backfill Plugs
In2Bones Global, Inc. today announced the U.S. commercial launch of its CoLink® Bone Graft Harvester and Tribio™ Backfill Plugs System. Packaged sterile and pre-assembled for single use, the CoLink Bone Graft Harvester is a minimally invasive bone graft device that harvests bone from various sites in the body, including the calcaneus, iliac crest, proximal tibia, distal tibia, and distal femur.…
Read MoreMed-botics Wearable Device Detects Opioid Overdose, and can Provide Early Warnings to Over-sedated Patients
The FDA granted Breakthrough Device status to Med-botics, LLC, (www.med-botics.com), for its Oxalert EPOTM (Enhanced Pulse Oximeter) device. The wrist-worn arousal device is designed to prevent respiratory arrest and death from opioid overdose. FDA Guidance documents describe Breakthrough Devices as “innovative technologies that diagnose or treat life-threatening conditions more effectively than any FDA-approved products.” The FDA…
Read MoreAnaconda Biomed Announces First-in-Human Study of Next-Generation Thrombectomy System
Anaconda Biomed, a medical technology company developing a next-generation thrombectomy system for the treatment of ischemic stroke, has announced the completion of initial patient cases in a first-in-human study at Hospital Vall d’Hebron in Barcelona. This 125-patient, prospective, multi-center study will assess system safety and reperfusion measured using the modified treatment in cerebral infarction (mTICI) score. Study…
Read MoreMedtronic Launches the First Artificial Intelligence System for Colonoscopy Capable of Automatically Detecting Possible Polyps
Medtronic plc, the global leader in medical technology, announced the launch of GI Genius™ intelligent endoscopy module at UEG Week in Barcelona, Spain. The GI Genius™ module is the first system worldwide using artificial intelligence to detect colorectal polyps. It provides physicians with a powerful new solution in the fight against colorectal cancer. The GI Genius…
Read MoreDiFusion Inc. Announces FDA 510K Clearance for its Spinal Interbody device, the Xiphos ZFUZE
DiFusion, Inc. today announced the FDA 510K clearance for the Xiphos-ZF Spinal interbody device. Xiphos-ZF is the first spinal implant developed from a new biomaterial called ZFUZE. Multiple studies have shown the ZFUZE material elicits pro-reparative M2 macrophage response and significant reductions in Interleukin 1-Beta and Interleukin 6. IL1-Beta and IL6 are cytokine markers for…
Read MoreStryker Announces Definitive Agreement to Acquire Wright Medical for $4B
Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). Wright Medical, which was founded in 1950, is a global medical…
Read MoreNarbis Launches Smart Glasses Using Neurofeedback and NASA-Developed Algorithm to Encourage Practicing Focus and Concentration
Narbis, a technology company dedicated to developing wellness products that encourage practicing focus and concentration, today announced the online availability of its proprietary Narbis smart glasses that use principles of neurofeedback and an algorithm developed by NASA to discourage distractibility and reward concentration while reading, working on the computer, studying, or doing homework. Narbis smart…
Read MoreFirst-of-its-Kind XACT Robotic System Cleared by FDA for Percutaneous Interventional Procedures
XACT Robotics™ Ltd. today announced that its first robotic system was cleared to market in the U.S. for use during computed tomography (CT) guided percutaneous interventional procedures. XACT’s technology is the first hands-free robotic system combining image-based planning and navigation with insertion and steering of various instruments to a desired target across an array of clinical…
Read More